Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：28
|
作者：
Tilly, H. [1 ]
Dreyling, M. [2 ]
机构：
[1] Ctr Henry Becquerel, Dept Hematol, Rouen, France
[2] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Med 3, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; TRANSPLANTATION; THERAPY;
D O I：
10.1093/annonc/mdp145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：110 / 112
页数：3
相关论文
共 50 条
  • [31] Non-Hodgkin's lymphoma in children and adolescents . From diagnostics to follow-up
    Ritter, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (11) : 1147 - 1161
  • [32] New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma
    Burton, Jack D.
    Goldenberg, David M.
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 569 - 583
  • [33] How the discovery of rituximab impacted the treatment of B-cell non-Hodgkin's lymphomas
    Mohammed, Raihan
    Milne, Artemis
    Kayani, Kayani
    Ojha, Utkarsh
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 71 - 84
  • [34] Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: where we stand
    Visani, Giuseppe
    Isidori, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 357 - 363
  • [35] Overview of antibody therapy in B-cell non-Hodgkin's lymphoma
    Wannesson, L
    Ghielmini, M
    CLINICAL LYMPHOMA, 2003, 4 : S5 - S12
  • [36] MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
    Lim, Emilia L.
    Marra, Marco A.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2013, 3 : 25 - 40
  • [37] Pembrolizumab for the treatment of diffuse large B-cell lymphoma
    Sheikh, Semira
    Kuruvilla, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1119 - 1126
  • [38] Emerging therapies for B-cell non-Hodgkin lymphoma
    Briones, Javier
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) : 1305 - 1316
  • [39] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    Aguiar Bujanda, David
    Aguiar Morales, Jose
    Bohn Sarmiento, Uriel
    Saura Grau, Salvador
    Rodriguez Franco, Carlos
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (09) : 604 - 608
  • [40] Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dreyling, M.
    Geisler, C.
    Hermine, O.
    Kluin-Nelemans, H. C.
    Le Gouill, S.
    Rule, S.
    Shpilberg, O.
    Walewski, J.
    Ladetto, M.
    ANNALS OF ONCOLOGY, 2014, 25 : 83 - 92
12345